• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.02% Nasdaq Up 0.41%

    PDL BioPharma, Inc. (PDLI)

    -NasdaqGS
    2.27 Down 0.04(1.73%) Feb 17, 4:00PM EST
    |After Hours : 2.27 0.00 (0.00%) Feb 17, 4:39PM EST
    Prev Close:2.31
    Open:2.31
    Bid:2.21 x 200
    Ask:2.35 x 200
    1y Target Est:3.67
    Beta:0.606657
    Next Earnings Date:23-Feb-17PDLI Earnings announcement
    Day's Range:2.25 - 2.32
    52wk Range:1.93 - 3.84
    Volume:1,726,851
    Avg Vol (3m):2,465,780
    Market Cap:375.78M
    P/E (ttm):2.15
    EPS (ttm):1.06
    Div & Yield:0.20 (8.81%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PDLI

    Comparison

    Symbol% ChgMkt Cap
    PDLIDown 1.73%375.78M
    AMGNUp 0.69%127.89B
    XOMAUp 2.14%31.81M
    SGENUp 0.31%9.27B

    Key Statistics

    Forward P/E (1 yr):11.35
    P/S (ttm):1.34
    Ex-Dividend Date:02-Jun-16

    Analysts

    Annual EPS Est (Dec-16) :0.54
    Quarterly EPS Est (Dec-16) :0.09
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):0.31

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    PDL BioPharma, Inc. manages a portfolio of patents and royalty assets in the United States and Europe. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback